Sponsor
Vienna, Austria —f-star is leveraging the ability to introduce additional binding sites into antibodies to create fully functional antibody fragments and multi-functional therapeutic candidates.
f-star is leveraging the ability to introduce additional binding sites into antibodies to create fully functional antibody fragments and multi-functional therapeutic candidates.
© Copyright 2012 Atlas Venture
LOGIN
